Endoscopic Devices - Poland

  • Poland
  • Revenue in the Endoscopic Devices market market in Poland is projected to reach US$249.80m in 2024.
  • Revenue is expected to exhibit an annual growth rate (CAGR 2024-2029) of 7.12%, which will lead to a market volume of US$352.40m by 2029.
  • In a global context, the highest revenue will be generated the United States, amounting to US$10,390.00m in 2024.
  • Poland's healthcare sector is increasingly adopting endoscopic devices, driven by a growing emphasis on minimally invasive surgical techniques and improved patient outcomes.

Key regions: Italy, United Kingdom, Netherlands, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Endoscopic Devices Market in Poland is witnessing moderate growth, influenced by factors such as technological advancements, increasing prevalence of chronic diseases, and the rising demand for minimally invasive procedures among healthcare providers and patients.

Customer preferences:
In Poland, there is a growing preference for advanced endoscopic procedures among patients and healthcare professionals, driven by an increasing awareness of the benefits of minimally invasive techniques. The aging population, coupled with a rise in chronic diseases, is leading to greater demand for early diagnosis and effective treatment options. Additionally, cultural shifts towards proactive health management are prompting more individuals to seek specialized care, resulting in a heightened acceptance of innovative endoscopic devices that enhance procedural efficiency and patient recovery.

Trends in the market:
In Poland, the Endoscopic Devices Market is experiencing a surge in the adoption of robotic-assisted and advanced imaging technologies, enhancing the precision of minimally invasive surgeries. Healthcare facilities are increasingly integrating these cutting-edge devices into their operations, driven by the demand for better patient outcomes and shorter recovery times. As a result, manufacturers are focusing on innovation and R&D to meet the evolving needs of healthcare providers. Furthermore, favorable government policies supporting medical technology investments are expected to accelerate market growth, presenting significant opportunities for industry stakeholders.

Local special circumstances:
In Poland, the Endoscopic Devices Market is influenced by a strong emphasis on healthcare innovation, supported by a highly educated medical workforce and a robust research environment. The country's geographical positioning facilitates collaboration with neighboring EU nations, enhancing the exchange of medical technologies. Additionally, Poland's regulatory framework aligns with EU standards, promoting the adoption of advanced medical devices. Cultural factors, such as a growing awareness of health and wellness, are driving patient demand for minimally invasive procedures, further stimulating market growth and innovation.

Underlying macroeconomic factors:
The Endoscopic Devices Market in Poland is shaped by various macroeconomic factors, including national economic health and global economic trends. Poland's stable GDP growth provides a conducive environment for healthcare investments, particularly in advanced medical technologies. The government's fiscal policies, emphasizing healthcare funding and innovation, bolster research and development in endoscopic devices. Moreover, the rising prevalence of lifestyle-related diseases and an aging population create a growing demand for minimally invasive surgical options, further driving market expansion. Additionally, the increasing collaboration with EU partners enhances technology transfer and accelerates the adoption of cutting-edge endoscopic solutions.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)